Detection of p53 gene mutations by single strand conformational polymorphism (SSCP) in human acute myeloid leukemia-derived cell lines

Leuk Res. 2002 Feb;26(2):207-14. doi: 10.1016/s0145-2126(01)00107-2.

Abstract

We have identified new mutations in the p53 gene in 3/11 growth factor-independent and in 2/8 growth factor-dependent human acute myeloid leukemia (AML)-derived cell lines by single-strand conformational polymorphism (SSCP) and sequencing analysis. MEG-01 had a triplet deletion at codon 304; F-36P, NB-4 and MV4-11 showed point mutations at codon 344. F-36P had a second point mutation at codon 270 and NB-4 additionally at codon 319. M-MOK had a nucleotide substitution at codon 191. The frequency of p53 mutations in the cytokine-independent cell lines was comparable to that in the cytokine-dependent lines. These results suggest that loss of Wild type (wt) p53 is not the decisive event causing tumor cells to proliferate in vitro without externally added growth factors.

MeSH terms

  • Acute Disease
  • Blotting, Western
  • Cell Division / drug effects
  • Codon / genetics
  • DNA Mutational Analysis
  • DNA, Neoplasm / genetics
  • Genes, p53*
  • Granulocyte Colony-Stimulating Factor / pharmacology*
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology*
  • Humans
  • Interleukin-3 / pharmacology*
  • Leukemia, Myeloid / genetics*
  • Leukemia, Myeloid / pathology
  • Point Mutation
  • Polymorphism, Single-Stranded Conformational
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • RNA, Neoplasm / biosynthesis
  • RNA, Neoplasm / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sequence Deletion
  • Tumor Cells, Cultured / chemistry
  • Tumor Cells, Cultured / drug effects
  • Tumor Suppressor Protein p53 / physiology

Substances

  • Codon
  • DNA, Neoplasm
  • Interleukin-3
  • RNA, Messenger
  • RNA, Neoplasm
  • Tumor Suppressor Protein p53
  • Granulocyte Colony-Stimulating Factor
  • Granulocyte-Macrophage Colony-Stimulating Factor